Affymax receives $5M payment for drug development - The Associated Press
Posted by admin / Under AnemiaAffymax receives $5M payment for drug development The Associated Press Biotechnology company Affymax Inc. has received a $5 million milestone payment from Takeda Pharmaceutical Co. for the development of a potential anemia ... Affymax(R) Receives $5 Million Milestone Payment on Initiation of Phase 3 ... Takeda makes milestone payment to Affymax over Hematide development |
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
Rockwell Medical Reports Excellent Fourth Quarter and Full Year 2009 Business ... - MarketWatch (press release)
Posted by admin / Under AnemiaRockwell Medical Reports Excellent Fourth Quarter and Full Year 2009 Business ... MarketWatch (press release) SFP is a novel, investigational, continuous iron therapy designed to treat iron deficiency anemia in ESRD patients. SFP is a proprietary, water-soluble form ... Rockwell Medical Reports Excellent Fourth Quarter and Full Year 2009 Business ... Rockwell Medical increases revenue, narrows losses Rockwell takes smaller 4Q loss on greater revenue |
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
'Saving Henry': Little Boy's Life Inspires New Hope - ABC News
Posted by admin / Under Anemia ABC News | 'Saving Henry': Little Boy's Life Inspires New Hope ABC News He also was born with Fanconi anemia, a rare and deadly disease no medicine could cure. Henry's life was spent in and out of hospitals, but his positive ... |
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
Anemia drugs help end-stage anemic kidney patients - Reuters
Posted by admin / Under AnemiaAnemia drugs help end-stage anemic kidney patients Reuters CHICAGO (Reuters) - Aggressive treatment with blockbuster anemia drugs may offer the best approach for kidney dialysis patients with severe anemia, ... For Some on Dialysis, Anemia Drugs Pose Risks Anemia Severity Impacts Benefit/Risk Of Amgen ESA Drugs Study of anemia drug outcomes in ESRD patients supports new guidelines |
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
Rockwell Medical Schedules Investor Conference Call - MarketWatch (press release)
Posted by admin / Under AnemiaRockwell Medical Schedules Investor Conference Call MarketWatch (press release) SFP is a novel, investigational, continuous iron therapy designed to treat iron deficiency anemia in ESRD patients. SFP is a proprietary, water-soluble form ... |
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
FDA unveils risk-management plan for Amgen anti-anemia drugs - Los Angeles Times
Posted by admin / Under AnemiaFDA unveils risk-management plan for Amgen anti-anemia drugs Los Angeles Times Reporting from Washington - Physicians who want to prescribe Amgen Inc.'s anti-anemia drugs for cancer patients will have to register and ... US sets risk plan for Amgen, J&J anemia drugs FDA asks Amgen, J&J to discuss anemia drug risks FDA Tightens Controls on Anemia Drugs |
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
Dialysis questions come on World Kidney Day - Pocono Record
Posted by admin / Under AnemiaDialysis questions come on World Kidney Day Pocono Record If needed, these include management of hypertension, edema or swelling, correction of anemia, management of vitamin D deficiency, management of bone disease ... Campaign launched to increase the number of Liverpool kidney patients getting ... |
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
Sickle-cell anemia deserves attention - Fredericksburg.com
Posted by admin / Under AnemiaSickle-cell anemia deserves attention Fredericksburg.com As parents of and advocates for those who suffer the debilitating, devastating effects of sickle-cell anemia, we were encouraged by the March 3 editorial ... |
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
Published on Thursday 11th of March 2010 06:59:56 AM
Read more...
